Abstract
Introduction
Hemangiomas are one of the most frequently encountered soft-tissue tumors.' They usually originate in the capillaries, but they sometimes arise in the venous vessels, as well. These tumors can be found in the skin , mucosa, bones, and viscera. In the sinonasal tract , the most common hemangiomatous lesions are capillary hemangiomas; angiomas and cavernous heman giom as are extremely rare.
Arterio venous malformations are vascular defects caused by the absence of normal capillary beds, which leads to the development of abnormal blood channel s that connect the arterial circulation to the venous circulation. Although vascular tumors in the head and neck are relatively common, particularly in the jaw, arteriovenous malformations are rare.' These defects are usually benign, but in some cases they can be life-threatenin g because of their potential for intractable bleedin g, Arterio venou s malformations are both congenital and acquired. Cases of acquired malform ation s are usually assoc iated with a history of surgery or blunt trauma.I In either case, an alternate blood pathw ay bypasses the normal high capillary resistance region and supplies it with an excessive amount of blood ; the incidence of hemorrhage is high.v' The most common symptom of this condition is the presence of a slowly growing mass in the maxilla or mandible following bleeding from the involved site.
In this article, we describe a case of arteriovenous malform ation in the maxillary sinus and mandible . We also discuss the important features of this condition and its treatment.
Case report A 9-yea r-old girl was referred to our institution for evaluation of recurrent episodes of hemorrhage from her nose and mouth . Her right cheek was swollen and her right second maxillary molar was loose. The history revealed that these symptoms had begun 4 years earlier. She had also been diagnos ed with a vascul ar tumor in the maxillary sinus I year earlier, and this had been treated by selective emboliza tion (figure I).
Computed tomography (CT) detected a nonhomogeneous soft-tissue mass with indistinct borders (figure 2). Angiography identified the nature of the tumor as a vascular mass that occupi ed the maxillary sinus. A blush was observe d in the mandibul ar regio n. Select ive embolization of the feeding vesse ls (i.e., the internal maxillary artery, the transverse facial artery, and the lingual and faci al arteries) via a femoral approach was performed with parti cles of different sizes. The malformation was fistulous, and venou s pockets were detected in the bony tissue. Following embolization, the patient
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Figure 1. Angiograph y demon strates the pati ent's original pre-embolization maxilla ry mass (A) and herpostembolization status (B) .
Note that the f eedin g vessels are occluded.
was taken to the operating room . With a gingivobuccal incision , a buccal flap was elevated and the anterior wall of the maxillary sinus was exposed. An antral window was made superior to the dental apices, and a lesion with indistinct borders was noted to be filling the maxillary sinus. The lesion was remov ed by curettage, and excessive bleeding was controlled with Surgicell and gauze packing. As the mass was being removed, the bleeding slowed. Following removal, the sinu s was packed with absorbable sponges. Histopathologic examination of the mass revealed that it contained normal mucosa and numerous irregul ar arterial and venous vascular channels. We established a diagnosis of arteriovenous malformation. The patient was discharged from the hospital after 3 days. She did well postoperatively for 4 months, but then she again began to experience bleeding from her mouth. Physical examination revealed active bleeding from the gingiva over the right mandibular molar. Angiography detected a mass in the mandible and a great deal of vascular feeding (figure 3). The maxillary sinu ses were clear. The lesion was embolized via a femoral artery approach, and the patient again underwent surgery . The vascul ar lesion in the mandible was extracted tran sorally, and the bony defect was closed with Medpore porous polyethylene (figure 4) . On continuing follow -up , the patient is free of disease and remain s well.
Discussion
Vascular tumors occur in the nasal cavity and nasopharynx more often than they do in the paranasal sinuses. ' Most of these tumors are capillary hemangiomas of osteogenic origin ." Arteriovenous malformations are not common in the maxillofacial region , but when they do occur in the maxilla or mandible, massive spont aneou s bleeding or iatrogenic bleeding during surgical interventions such as tooth extraction can occur .' A slowl y grow ing, expansile 610 mass in the maxilla or mandibl e accompanied by spontaneous gingival bleeding near the affected site are the most common symptoms of arteriovenous malformation. Paresthesia, mobility of the invol ved teeth, gingival discoloration, hypertherm ia over the lesion , a feeling of pulsation , and pain might also be evident. Bruit s or pulsations can be detect ed in larg e hemangiom as. On the other hand, some of these tumors have no signs or symptoms." Our patient' s primary symptom was spontaneous bleeding from the right second maxillary molar. Her physical examination reveal ed a slight discoloration of the maxillary gingiva and mobility of the right second maxillary molar. She had no history of trauma. The se findings were con sistent with the data in the literature. After her first operation, anot her vascular tumor was detected in the mandible , and this mass was successfully extracted after 
. Intraoperative photographs show the mandibular def ect (A) and the Medpore implant (B).
sion to arteriovenous malformations." We first tried to treat the vascu lar lesion in our patient with embolization with particles alone, but becau se recurrence was detected both clinically and radiologically, we ultimately operated and comp letely removed the lesion fro m the maxillary sinus cavi ty. When the patient' s bleeding recurred 4 months later, rad iolog ic and angiographic inves tigations demonstrated a mass in the mandible. After selective embolization, we operated again and the mass was removed by curettage . embolization. We could not find any other report in the literature of involvement of the max illary sinus and mandible at approximately the same time .
Darlow et al wrote of the diagnostic importance of differentiating between a vascular lesion and a high ly vascular mucosa cau sed by an inflammatory proce ss.' They recommended routine aspiration of all expansile lesions in the maxillofacial region. Direct radiography can demonstrate multilocular radio lucencies in the involved bone. Furt hermore, CT can detect a highly vascular mass with multiple lobulations. Angiography is the most useful imaging moda lity; in fact , it is essential to confirm the diag nos is as well as to eval uate the vasc ular architecture." In our patient, CT demonstrated that a multilobular mass with indis tinct borders was present in the maxillary sinus. The tumor had invaded the palatin e portion of the maxilla. Massive hemorrhage from the gingiva l mucosa led us to the preoperative differential diagnosi s of a vascu lar tumor. We performed angiography, which demonstrated the hig h degree of vasc ularity in the tumor.
Tre ating arteriovenous malformations is difficult. The primary treatment goal s are to stop bleeding and to prevent its recurrence.10 The treatment itself invol ves surgical excision or complete oblite ration by embolization.II Complete resection of an arteriovenous malformation following embolization is the safest treatment, but resection can cause functional and cosmetic defects, especially in the mand ibular region. 7.10 Surgical curettage following preoperative embolization or ligat ure has been tried; altho ugh this method is more conservative, the risk of recurrence is high. 10. 12 Selective embo lizatio n with particles or glue and direct transo sseo us puncture alone have also been repo rted. After the inventio n of steel coils for intravascular embolization in the 1970s, coil embolization was successfully used to produce permanent occl u-
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Because recurrence followin g embolization for arteriovenous malformation s is frequent, follow-up angiography and radiography are important. In our patient, the blush in the mandib ular region was detected during the embolization prior to the first operation, but because there was no active filling, embolization and curettage were not performed. But the embolized branches revasc ularized quickly, and the second lesion became apparent within 4 month s.
In a study of 85 paranasal vascula r tumors, Fu and Perzin did not detect any case of arteriovenous malformation in the maxillary region ." In fact, the only such case in the literature was reported by Darlow et al in 1988. 
